|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 990.33 USD | +0.72% |
|
-5.86% | -7.85% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Discovery, Dev., Manufacturing, Marketing, and Sales of Pharmaceutical Products | 28.32B | 28.54B | 34.12B | 45.04B | 65.18B | |||||
Total Assets | 48.81B | 49.49B | 64.01B | 78.71B | 112B | |||||
Interest Expense | -340M | -332M | -486M | -781M | - | |||||
Income Tax Expense | 574M | 562M | 1.31B | 2.09B | 5.09B | |||||
CAPEX | -1.87B | -2.48B | -3.45B | -5.06B | -7.84B | |||||
EBT | 6.16B | 6.81B | 6.55B | 12.68B | 25.73B | |||||
D&A | 1.55B | 1.52B | 1.53B | 1.77B | 2B | |||||
Net Income | 5.58B | 6.24B | 5.24B | 10.59B | 20.64B | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Veterinary Drugs | ||||||||||
Animal Health Products | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
D&A | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S.) | 16.81B | 18.19B | 21.79B | 30.38B | 43.48B | |||||
Total Assets | - | - | - | - | - | |||||
Europe | 4.78B | 4.3B | 6.17B | 6.92B | 11.56B | |||||
Total Assets | - | - | - | - | - | |||||
Rest of world | 2.7B | 2.85B | 2.95B | 4.27B | 6.06B | |||||
Total Assets | 1.69B | 1.63B | 1.78B | 2.16B | 3.52B | |||||
Japan | 2.37B | 1.75B | 1.67B | 1.81B | 2.13B | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | 6.62B | 7.71B | 9.99B | 13.4B | 18.76B | |||||
Total Assets | 1.7B | 1.9B | 2.72B | 3.2B | 4.32B | |||||
China | 1.66B | 1.45B | 1.54B | 1.66B | 1.95B |
- Stock Market
- Equities
- LLY Stock
- Financials Eli Lilly and Company
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















